Melatonin and Heart health: Emerging Risks to a Popular Sleep Aid
Despite its widespread use as a natural sleep remedy, emerging research suggests a complex and possibly concerning relationship between melatonin supplementation and cardiovascular health. A recent report detailed in National Geographic highlights growing ambiguity surrounding the impact of this readily available supplement on the heart.
For millions seeking relief from sleep disorders and other ailments, melatonin has become a go-to solution, perceived as a safe and natural alternative to prescription medications. However, the scientific literature is increasingly revealing a more nuanced picture, with some studies pointing to worrying results regarding its effects on the cardiovascular system.
Melatonin is a hormone naturally produced by the pineal gland, playing a crucial role in regulating the body’s circadian rythm and sleep-wake cycle. Its ability to promote sleep has fueled its popularity, notably among those struggling with rest. While marketed as a natural option, the perception of safety doesn’t always align with the latest scientific data. “Science still faces difficulties in clarifying the complexities surrounding this seemingly simple supplement,” warned a cardiologist at NYU Langone Hospital in National Geographic.
At the molecular level,melatonin interacts with MT and MT receptors found in both the brain and cardiovascular tissues – including blood vessels and heart muscle. This interaction extends beyond sleep, influencing vascular tone, heart rate, and signaling within the autonomic nervous system. According to another cardiologist at NYU Langone Hospital, melatonin “acts as a signaling molecule with direct and indirect effects on the cardiovascular system.”
The body’s response to melatonin supplementation varies significantly depending on factors like dosage, timing, formulation, concurrent medications, and pre-existing health conditions. Research has explored potential benefits, with some studies suggesting modest reductions in nighttime blood pressure for individuals with hypertension and improvements in certain parameters related to type two diabetes and associated hypertension.
furthermore, melatonin exhibits antioxidant and anti-inflammatory properties. Preclinical studies have indicated a reduction in cardiac damage following heart attacks, during surgical procedures, or a decrease in oxidative stress markers. Its potential to alleviate symptoms in people with heart failure is also under examination. Though, a former president of the American Heart Association emphasized in National Geographic that while thes antioxidant mechanisms are promising, robust clinical evidence supporting the widespread use of melatonin for cardiovascular protection remains lacking.
The scientific record also documents potential risks associated with melatonin consumption, particularly with prolonged use or in individuals with pre-existing medical conditions. A notable observational analysis presented at the 2025 American heart Association Scientific Sessions revealed that adults with insomnia who used melatonin for at least a year had an approximately 90% higher risk of developing heart failure within the next five years compared to non-users.
While these studies don’t establish a direct causal link, “the magnitude of the association is large enough to set off alarm bells,” especially for those already at cardiovascular risk, according to one expert.Interactions between melatonin and certain medications, such as calcium channel blockers, have also been reported, potentially diminishing the antihypertensive effects of these treatments.
A clinical professor of medicine at Stanford University cautioned against recommending melatonin due to observed associations with heart failure. However, this perspective was countered by another expert who argued that a broader analysis of the data doesn’t support important harm, particularly at low or physiological doses.
Research exploring the connection between melatonin and heart health remains fragmented. Many studies are short-term, utilize diverse formulations and dosages, and often fail to reach definitive conclusions. “Elucidating long-term cardiovascular safety will require larger-scale trials, with long follow-up and clear differentiation between pharmaceutical and over-the-counter melatonin, whose concentration and purity vary widely,” explained a researcher in National Geographic. Currently, there are no definitive answers regarding the risks or benefits of melatonin supplements for the general population.
Until more conclusive data emerges,experts recommend exercising caution. Melatonin may be useful under medical supervision in specific cases, such as for shift workers, individuals experiencing frequent jet lag, or those with sleep-wake delay disorder. Experts advise choosing the lowest effective dose, avoiding long-term use, taking melatonin 30 to 90 minutes before bedtime, and opting for products verified by autonomous laboratories. Monitoring blood pressure and heart rate during use is also recommended.
For individuals with existing heart disease or those taking cardiovascular medications, consulting a physician is essential. Maintaining healthy lifestyle habits – including regular physical activity, a balanced diet, and adequate rest – remains the cornerstone of cardiovascular care, experts emphasize.
While science continues to evolve, specialists suggest not dismissing melatonin as a sleep aid entirely, but rather remaining vigilant and exploring safer alternatives to protect the heart and address diagnosed pathologies.
